Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae

Abstract Background Oral beta-lactam antimicrobials are not routinely tested against Streptococcus pneumoniae due to presumed susceptibility based upon penicillin minimum inhibitory concentration (MIC) testing. Currently, Clinical and Laboratory Standards Institute provides comments to use penicilli...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mark E. Murphy, Eleanor Powell, Joshua Courter, Joel E. Mortensen
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2021-07-01
Edice:	BMC Infectious Diseases
Témata:	Streptococcus pneumoniae Susceptibility testing; pneumococcus Beta-lactams (β-lactams) Cefdinir
On-line přístup:	https://doi.org/10.1186/s12879-021-06341-y
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!